Skip to main content
Clinical Trials/NCT03327207
NCT03327207
Unknown
Not Applicable

Exploring Interactions Between Growth Hormone and the Microbiome

Rambam Health Care Campus1 site in 1 country200 target enrollmentNovember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Growth Hormone Deficiency
Sponsor
Rambam Health Care Campus
Enrollment
200
Locations
1
Primary Endpoint
Changes in the microbiome population following Growth hormone treatment
Last Updated
5 years ago

Overview

Brief Summary

The goal of this study is to characterize the microbiome and metabolomics of children with Growth Hormone (GH) deficiency, prior GH treatment initiation and compare it to healthy children

Registry
clinicaltrials.gov
Start Date
November 1, 2017
End Date
November 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children with GH deficiency

Exclusion Criteria

  • Turner syndrome
  • End state renal disease (ESRD)
  • Prader-Willi syndrome
  • Systemic illness
  • Antibiotics/Antifungal in the last 3m

Outcomes

Primary Outcomes

Changes in the microbiome population following Growth hormone treatment

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials